184 related articles for article (PubMed ID: 34664787)
1. Studies on CYP3A activity during the menstrual cycle as measured by urinary 6β-hydroxycortisol/cortisol.
Bergström H; Lindahl A; Warnqvist A; Diczfalusy U; Ekström L; Björkhem-Bergman L
Pharmacol Res Perspect; 2021 Dec; 9(6):e00884. PubMed ID: 34664787
[TBL] [Abstract][Full Text] [Related]
2. Quantification of cortisol and 6 beta-hydroxycortisol in human urine by LC-MS/MS, and gender-specific evaluation of the metabolic ratio as biomarker of CYP3A activity.
Lutz U; Bittner N; Ufer M; Lutz WK
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):97-101. PubMed ID: 19959402
[TBL] [Abstract][Full Text] [Related]
3. The influence of taurine and L-carnitine on 6 β-hydroxycortisol/cortisol ratio in human urine of healthy volunteers.
Makhova AA; Shikh EV; Bulko TV; Sizova ZM; Shumyantseva VV
Drug Metab Pers Ther; 2019 Oct; 34(3):. PubMed ID: 31603853
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological study of urinary 6beta-hydroxycortisol to cortisol ratios and breast cancer risk.
Zheng W; Jin F; Dunning LA; Shu XO; Dai Q; Wen WQ; Gao YT; Holtzman JL
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):237-42. PubMed ID: 11303593
[TBL] [Abstract][Full Text] [Related]
5. Associations of the CYP3A5*3 and CYP3A4*1G polymorphisms with the pharmacokinetics of oral midazolam and the urinary 6β-hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male Chinese.
Chan SW; Xiao Y; Hu M; Yin OQ; Chu TT; Fok BS; Lee VH; Tomlinson B
J Clin Pharm Ther; 2016 Oct; 41(5):552-8. PubMed ID: 27511886
[TBL] [Abstract][Full Text] [Related]
6. Diurnal variation of 6beta-hydroxycortisol in cardiac patients.
Micuda S; Sispera L; Hodac M; Parízek P; Fuksa L; Brcáková E; Cerman J; Cermanová J; Martínková J
Physiol Res; 2007; 56(3):307-313. PubMed ID: 16792464
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
Ushiama H; Echizen H; Nachi S; Ohnishi A
Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
[TBL] [Abstract][Full Text] [Related]
8. Influence of amiodarone on urinary excretion of 6beta-hydroxycortisol in humans.
Micuda S; Hodac M; Sispera L; Parízek P; Pleskot M; Zimova G; Cerman J; Martínková J; Pidrman V
Physiol Res; 2001; 50(2):191-6. PubMed ID: 11522047
[TBL] [Abstract][Full Text] [Related]
9. Gas chromatography-mass spectrometry measurement of 6beta-OH-cortisol/cortisol ratio in human urine: a specific marker of enzymatic induction.
Luceri F; Fattori S; Luceri C; Zorn M; Mannaioni P; Messeri G
Clin Chem Lab Med; 2001 Dec; 39(12):1234-9. PubMed ID: 11798083
[TBL] [Abstract][Full Text] [Related]
10. Differences in the urinary excretion of 6-beta-hydroxycortisol/cortisol between Asian and Caucasian women.
Lin Y; Anderson GD; Kantor E; Ojemann LM; Wilensky AJ
J Clin Pharmacol; 1999 Jun; 39(6):578-82. PubMed ID: 10354961
[TBL] [Abstract][Full Text] [Related]
11. Urinary 6β-Hydroxycortisol/Cortisol Ratio Most Highly Correlates With Midazolam Clearance Under Hepatic CYP3A Inhibition and Induction in Females: A Pharmacometabolomics Approach.
Shin KH; Ahn LY; Choi MH; Moon JY; Lee J; Jang IJ; Yu KS; Cho JY
AAPS J; 2016 Sep; 18(5):1254-1261. PubMed ID: 27317471
[TBL] [Abstract][Full Text] [Related]
12. Variations in biomarkers of dyslipidemia and dysbiosis during the menstrual cycle: a pilot study in healthy volunteers.
Bergström H; Ekström L; Warnqvist A; Bergman P; Björkhem-Bergman L
BMC Womens Health; 2021 Apr; 21(1):166. PubMed ID: 33879161
[TBL] [Abstract][Full Text] [Related]
13. Circadian variation of the urinary 6beta-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity.
Ohno M; Yamaguchi I; Ito T; Saiki K; Yamamoto I; Azuma J
Eur J Clin Pharmacol; 2000; 55(11-12):861-5. PubMed ID: 10805065
[TBL] [Abstract][Full Text] [Related]
14. Effect of troglitazone on urinary excretion of 6beta-hydroxycortisol.
Koup JR; Anderson GD; Loi CM
J Clin Pharmacol; 1998 Sep; 38(9):815-8. PubMed ID: 9753209
[TBL] [Abstract][Full Text] [Related]
15. Within-person variability of urinary 6beta-hydroxycortisol to urinaryl ratios in Caucasian women.
Chen Z; Dunning LA; Anderson KE; Holtzman JL; Zheng W
Steroids; 2004 Jan; 69(1):67-70. PubMed ID: 14715379
[TBL] [Abstract][Full Text] [Related]
16. Interindividual and intraindividual variability of the urinary 6beta-Hydroxycortisol/Cortisol ratio in Chinese subjects: implications of its use for evaluating CYP3A activity.
Yin OQ; Shi X; Tomlinson B; Chow MS
J Clin Pharmacol; 2004 Dec; 44(12):1412-7. PubMed ID: 15545313
[TBL] [Abstract][Full Text] [Related]
17. [Effect of mexidol on 6beta/free hydroxycortisol ratio. Possibility of CYP3A4 activation].
Baranov PA; Appolonova SA; Rodchenkov GM; Sariev AK; Zherdev VP
Eksp Klin Farmakol; 2010 Nov; 73(11):39-40. PubMed ID: 21254598
[TBL] [Abstract][Full Text] [Related]
18. Increase in urinary excretion of 6beta-hydroxycortisol in common marmosets as a marker of hepatic CYP3A induction.
Totsuka S; Watanabe T; Koyanagi F; Tanaka K; Yasuda M; Manabe S
Arch Toxicol; 1999; 73(4-5):203-7. PubMed ID: 10463384
[TBL] [Abstract][Full Text] [Related]
19. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women.
Benzi JRL; Moreira FL; Marques MP; Duarte G; Suarez-Kurtz G; Lanchote VL
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1144():122074. PubMed ID: 32247187
[TBL] [Abstract][Full Text] [Related]
20. Poor correlation between 6beta-hydroxycortisol:cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activity.
Chen YC; Gotzkowsky SK; Nafziger AN; Kulawy RW; Rocci ML; Bertino JS; Kashuba AD
Br J Clin Pharmacol; 2006 Aug; 62(2):187-95. PubMed ID: 16842393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
